XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of performance-based awards

​

​

​

​

​

​

​

​

​

​

​

​

​

Period Granted

​

Options Granted

​

RSUs Granted

​

Options Vested

​

RSUs Vested

​

Milestone

​

Valuation Method

(in thousands)

Q1 2019

​

200

​

300

​

169

​

260

​

(1)

​

Monte-Carlo Simulation

Q2 2019

​

—

​

188

​

—

​

81

​

(2)

​

Fair Market Value

Q3 2019

​

—

​

50

​

—

​

38

​

(1)

​

Monte-Carlo Simulation

Q1 2020

​

150

​

300

​

94

​

216

​

(1)

​

Monte-Carlo Simulation

Q1 2020

​

—

​

436

​

—

​

404

​

(3)

​

Fair Market Value

Q1 2020

​

129

​

—

​

129

​

—

​

(3)

​

Black-Scholes-Merton

Q2 2020

​

—

​

21

​

—

​

21

​

(3)

​

Fair Market Value

Q3 2020

​

10

​

—

​

10

​

—

​

(4)

​

Black-Scholes-Merton

Q3 2020

​

—

​

27

​

—

​

13

​

(3)

​

Fair Market Value

Q4 2020

​

—

​

32

​

—

​

6

​

(1)

​

Monte-Carlo Simulation

Q4 2020

​

—

​

22

​

—

​

2

​

(5)

​

Fair Market Value

Q1 2021

​

150

​

125

​

—

​

—

​

(1)

​

Monte-Carlo Simulation

Q1 2021

​

—

​

279

​

—

​

10

​

(3)

​

Fair Market Value

Q2 2021

​

163

​

—

​

—

​

—

​

(1)

​

Monte-Carlo Simulation

Q2 2021

​

29

​

—

​

—

​

—

​

(3)

​

Black-Scholes-Merton

Q2 2021

​

—

​

7

​

—

​

—

​

(3)

​

Fair Market Value

________________________________

(1) The awards will vest based on the achievement of certain values of the Company’s common stock at multiple thresholds within certain periods and are contingent upon the completion of requisite service through the date of such vesting.

​

(2) The vesting of the awards will be triggered after the end of the achievement milestone, as measured by the Company.

​

(3) The awards will vest based on achievement of a revenue target and are contingent upon the completion of requisite service through the date of such vesting.

​

(4) The awards vest based on achievement of a reimbursement target.

​
(5) The awards will vest based on achievement of certain revenue and recruiting targets.

Summary of stock option activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Outstanding Options

​

    

​

    

​

    

​

    

Weighted-

    

​

​

​

​

​

​

​

Weighted-

​

Average

​

​

​

​

Shares

​

​

​

Average

​

Remaining

​

Aggregate

​

​

Available for

​

Number of

​

Exercise

​

Contractual

​

Intrinsic

(in thousands, except for contractual life and exercise price)

​

Grant

​

Shares

​

Price

​

Life

​

Value

​

​

​

​

​

​

​

​

​

(in years)

​

​

Balance at December 31, 2020

 

3,197

 

6,707

​

$

11.19

​

6.04

​

$

592,468

Additional shares authorized

 

3,446

​

—

​

​

​

​

​

​

​

​

Options granted

 

(390)

 

390

​

$

104.01

​

​

​

​

​

Options exercised

 

—

 

(782)

​

$

8.73

​

​

​

​

​

Options forfeited/cancelled

 

31

 

(31)

​

$

13.80

​

​

​

​

​

RSUs granted

​

(1,355)

​

—

​

​

​

​

​

​

​

​

RSUs forfeited/cancelled

​

164

​

—

​

​

​

​

​

​

​

​

Balance at June 30, 2021

 

5,093

 

6,284

​

$

17.25

​

5.93

​

$

605,986

Exercisable at June 30, 2021

​

​

 

4,823

​

$

9.93

​

5.23

​

$

499,683

Vested and expected to vest at June 30, 2021

​

​

 

6,194

​

$

16.90

​

5.90

​

$

599,432

Restricted stock units

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

Average

​

​

​

​

Grant Date

(in thousands, except for grant date fair value)

​

Shares

​

Fair Value

​

​

​

​

​

​

Balance at December 31, 2020

​

4,188

​

$

34.02

Granted

​

1,355

​

$

103.67

Vested

​

(1,387)

​

$

26.50

Cancelled/forfeited

​

(164)

​

$

41.33

Balance at June 30, 2021

​

3,992

​

$

59.73

Summary of stock-based compensation expenses

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended June 30, 

​

​

2021

​

2020

​

    

Employee

    

Non-Employee

    

Total

    

Employee

    

Non-Employee

    

Total

​

​

(in thousands)

Cost of revenues

​

$

1,275

​

$

—

​

$

1,275

​

$

441

​

$

—

​

$

441

Research and development

​

 

6,276

​

 

340

​

 

6,616

​

 

2,631

​

 

282

​

 

2,913

Selling, general and administrative

​

 

27,146

​

 

66

​

 

27,212

​

 

8,527

​

 

76

​

 

8,603

Total

​

$

34,697

​

$

406

​

$

35,103

​

$

11,599

​

$

358

​

$

11,957

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Six months ended June 30, 

 

​

​

2021

​

2020

 

​

    

Employee

    

Non-Employee

    

Total

    

Employee

    

Non-Employee

    

Total

 

​

 

(in thousands)

​

Cost of revenues

​

$

1,983

​

$

—

​

$

1,983

​

$

755

​

$

—

​

$

755

​

Research and development

​

 

9,926

​

 

564

​

 

10,490

​

 

4,313

​

 

442

​

 

4,755

​

Selling, general and administrative

​

 

45,751

​

 

111

​

 

45,862

​

 

13,779

​

 

85

​

 

13,864

​

Total

​

$

57,660

​

$

675

​

$

58,335

​

$

18,847

​

$

527

​

$

19,374

​

Performance-based awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions used in valuation of fair value

​

​

​

​

​

​

​

​

​

June 30, 

​

2021

Risk-free interest rate

​

0.80

%

—

1.42

%

Expected dividend yield

​

​

​

​

0.00

%

Expected volatility

​

​

​

​

60

%

Expected term (years)

​

7.25

​

—

10.00

​

Employee stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions used in valuation of fair value

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended June 30, 

​

Six months ended June 30, 

​

    

2021

    

    

2020

    

​

2021

​

2020

​

Expected term (years)

 

5.11

​

—

10.00

​

 

​

​

​

10.00

​

​

5.11

​

—

10.00

​

​

5.27

​

—

10.00

​

Expected volatility

 

56.01

%

—

63.30

%

 

​

​

​

53.94

%

​

55.33

%

—

63.30

%

​

49.94

%

—

58.53

%

Expected dividend rate

 

​

​

​

0.00

%

 

​

​

​

0.00

%

​

​

​

​

0.00

%

​

​

​

​

0.00

%

Risk-free interest rate

 

0.81

%

—

1.67

%

 

​

​

​

0.71

%

​

0.81

%

—

1.67

%

​

0.44

%

—

1.70

%